Stay updated on Gantenerumab Long-term Safety in AD Clinical Trial

Sign up to get notified when there's something new on the Gantenerumab Long-term Safety in AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gantenerumab Long-term Safety in AD Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T08:38:07.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T19:13:20.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The site shows a revision update from v3.4.1 to v3.4.2. No changes to core study details or navigation are observed.
    Difference
    0.0%
    Check dated 2026-02-13T12:13:08.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A new revision tag (v3.4.1) was added and the previous revision (v3.4.0) removed; there are no changes to the study content or visible page information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:16:56.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and the previous Revision: v3.3.3 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T05:06:22.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Locations section expanded to include new regional sites across the US and internationally (Arizona, California, Florida, Michigan, New York, North Carolina, Oklahoma, Tennessee, Texas, South Australia, Victoria, Nova Scotia, Ontario, Emilia-Romagna, Lombardy, Mexico City, Nuevo León, Sankt-Peterburg, Alicante, Barcelona) and updated to v3.3.3; some previous location groupings were removed.
    Difference
    2%
    Check dated 2025-12-24T15:10:21.000Z thumbnail image

Stay in the know with updates to Gantenerumab Long-term Safety in AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gantenerumab Long-term Safety in AD Clinical Trial page.